评估危重症幸存者长期结局时需考虑竞争事件
本文为视角文章,探讨危重症幸存者出院后长期结局评估中竞争事件(如随访期间全因死亡,该事件阻止了感兴趣事件的发生)带来的挑战和方法学影响。作者指出,无竞争事件时常用的Kaplan-Meier法和Cox比例风险模型在存在竞争事件时可产生偏倚估计。文章介绍了不同的估计目标以及多种分析策略,包括改变感兴趣结局、Fine and Gray回归模型、病因特异Cox比例风险模型和广义方法(如逆概率加权),并提供代码和模拟数据集以示例不同分析策略的应用及总体报告建议。
要点
- 危重症幸存者长期结局评估中,竞争事件(如随访期间全因死亡)可阻止感兴趣事件的发生,传统Kaplan-Meier法和Cox模型在存在竞争事件时可产生偏倚估计。
- 作者介绍了不同估计目标及分析策略,包括改变感兴趣结局、Fine and Gray回归模型、病因特异Cox比例风险模型和广义方法(如逆概率加权)。
- 文章提供代码和模拟数据集,以示例不同分析策略的应用,并给出总体报告建议。
适用人群与场景
- 危重症幸存者出院后的长期结局评估场景。
研究设计与关键结果
- 本文为视角文章,探讨危重症幸存者长期结局评估中竞争事件的方法学挑战与影响。
- 无竞争事件时,评估长期结局常用Kaplan-Meier法和Cox比例风险模型分析时间-事件(生存)数据。
- 存在竞争事件时,传统分析和建模技术可产生偏倚估计。
- 作者介绍了不同估计目标及多种分析策略,包括改变感兴趣结局、Fine and Gray回归模型、病因特异Cox比例风险模型和广义方法(如逆概率加权)。
- 文章提供代码和模拟数据集,以示例不同分析策略的应用,并给出总体报告建议。
证据类型、等级与局限
- 证据类型:视角文章。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The clinical trajectory of survivors of critical illness after hospital discharge can be complex and highly unpredictable. Assessing long-term outcomes after critical illness can be challenging because of possible competing events, such as all-cause death during follow-up (which precludes the occurrence of an event of particular interest). In this perspective, we explore challenges and methodological implications of competing events during the assessment of long-term outcomes in survivors of critical illness. In the absence of competing events, researchers evaluating long-term outcomes commonly use the Kaplan-Meier method and the Cox proportional hazards model to analyze time-to-event (survival) data. However, traditional analytical and modeling techniques can yield biased estimates in the presence of competing events. We present different estimands of interest and the use of different analytical approaches, including changes to the outcome of interest, Fine and Gray regression models, cause-specific Cox proportional hazards models, and generalized methods (such as inverse probability weighting). Finally, we provide code and a simulated dataset to exemplify the application of the different analytical strategies in addition to overall reporting recommendations.
参考来源
- Angriman F, Ferreyro BL, Harhay MO, et al. Accounting for Competing Events When Evaluating Long-Term Outcomes in Survivors of Critical Illness. Am J Respir Crit Care Med. 2023. PMID: 37769125. doi:10.1164/rccm.202305-0790CP
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。